News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
42 Results
Type
Article (1)
Press Release (41)
Section
Business (22)
Deals (1)
Drug Development (2)
News (25)
Tag
Academia (1)
Alliances (13)
Cancer (1)
Clinical research (1)
Earnings (2)
Events (7)
Gene therapy (1)
Mergers & acquisitions (1)
People (6)
Phase II (1)
Preclinical (1)
Real estate (1)
Date
Last 365 days (1)
2024 (1)
2023 (2)
2020 (2)
2019 (2)
2018 (7)
2017 (7)
2016 (12)
2015 (5)
2014 (1)
2013 (3)
Location
Asia (2)
Europe (34)
42 Results for "synpromics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
uniQure incorporates novel synthetic promoter developed by Synpromics in new
Synpromics is pleased to hear that its partner, uniQure (NASDAQ:QURE), has announced the incorporation of its promoter, developed by Synpromics, in a new preclinical research target.
December 5, 2018
·
3 min read
Deals
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
Synpromics to operate as a wholly owned subsidiary; the two companies bring together pioneering technology to increase efficacy of gene therapeutics
August 13, 2019
·
6 min read
Business
Lonza chooses Synpromics’ novel inducible promoter platform to manufacture biopharmaceuticals
Lonza and Synpromics worked together to develop and test these innovative promoters in Lonza’s industry-leading GS Xceed® Expression System.
May 16, 2019
·
4 min read
Synpromics Promoter Technology Moves Closer to the Clinic
Synpromics is pleased to announce positive data presented today by a key partner, uniQure (NASDAQ:QURE), at the European Society of Gene and Cell Therapy conference in Lausanne, Switzerland.
October 18, 2018
·
2 min read
Synpromics Unveils Next Generation Liver Selective and Tunable Promoter Platform
Synpromics is today unveiling its novel drug-regulatable promoter platform at the European Society of Cell and Gene Therapy (ESGCT) congress in Lausanne, Switzerland.
October 17, 2018
·
3 min read
Synpromics named among the top 50 fastest growing technology companies in the UK
Synpromics, the leader in gene control, is delighted to announce that it has been ranked 12th in the Deloitte ‘UK Technology Fast 50’ at the annual awards ceremony in London last night.
November 16, 2018
·
4 min read
Business
Synpromics awarded Innovate UK grant to evaluate its inducible promoter platform in collaboration with Lonza Pharma & Biotech
Synpromics Ltd announces a partnership with Lonza Pharma & Biotech to further develop its inducible promoter system and improve manufacturing of biopharmaceuticals.
April 24, 2018
·
4 min read
Business
Synpromics Announces New Partnership with UCL to Develop Novel Gene Therapies for Blood-Based Disorders
This new partnership further expands Synpromics’ activities in the cell and gene therapy sector, as it builds on its strategy of establishing partnerships with leading academics in the UK to integrate its technology into the next generation of gene-based medicines.
January 25, 2018
·
4 min read
Press Releases
Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy
November 18, 2024
·
7 min read
Business
Synpromics Announces Gene Therapy Research Partnership With Solid Biosciences
September 20, 2017
·
3 min read
1 of 5
Next
